A gene-editing tool called Crispr-Cas9 has sparked millions of dollars of investments. Rival research teams that claim patents are going to court to determine who owns the commercial rights.

Topics:  crispr-cas9   owns   gene   court   

 

Welcome to Wopular!

Welcome to Wopular

Wopular is an online newspaper rack, giving you a summary view of the top headlines from the top news sites.

Senh Duong (Founder)
Wopular, MWB, RottenTomatoes

Subscribe to Wopular's RSS Fan Wopular on Facebook Follow Wopular on Twitter Follow Wopular on Google Plus

MoviesWithButter : Our Sister Site

More Business News